New Drug Extends Survival for Men With Advanced Prostate
Cancer
THURSDAY, May 26 (HealthDay News) --
For men with advanced hormone-resistant prostate cancer who have also failed chemotherapy, the new drug Zytiga (abiraterone acetate) along with the steroid prednisone appears to boost survival, researchers report."
